You have 9 free searches left this month | for more free features.

SC-58635

Showing 1 - 25 of 1,494

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Colonoscopy Biopsy)

Completed
  • Familial Adenomatous Polyposis
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 10, 2022

Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena

Active, not recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Duarte, California
  • +1 more
Mar 17, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Colorectal Cancer, Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Placebo, eflornithine)

Completed
  • Colorectal Cancer
  • Familial Adenomatous Polyposis
  • Houston, Texas
    M D Anderson Cancer Center
Sep 8, 2020

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Adenomatous Polyposis Coli Trial in Worldwide (Celecoxib, Placebo)

Terminated
  • Adenomatous Polyposis Coli
  • Chicago, Illinois
  • +42 more
Feb 18, 2021

Melanoma Trial in Worldwide (relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab)

Not yet recruiting
  • Melanoma
  • Anchorage, Alaska
  • +28 more
Oct 20, 2023

Multiple Myeloma, Myeloma Multiple, Myeloma Trial in Poitiers (Drug and medical device)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Drug and medical device
  • Poitiers, France
    CHU Poitiers
Jun 1, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)

Recruiting
  • Alzheimer Disease
  • Daejeon, Korea, Republic of
    Chungnam National University Hospital
Nov 17, 2023

Myositis Trial (EFG PH20 SC)

Not yet recruiting
  • Myositis
  • EFG PH20 SC
  • (no location specified)
Jul 28, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Injectable Contraception Cohort Study in Punjab, Pakistan

Not yet recruiting
  • Contraceptive Usage
  • Contraceptive usage
  • (no location specified)
Mar 7, 2023

Relapsed/Refractory Multiple Myeloma Trial (Isatuximab, Carfilzomib, Dexamethasone)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • (no location specified)
Feb 3, 2023

Healthy Volunteers Trial (ABP 501, Adalimumab)

Completed
  • Healthy Volunteers
  • (no location specified)
Aug 9, 2023

Von Willebrand Diseases Trial in Vienna (VGA039, Placebo)

Recruiting
  • Von Willebrand Diseases
  • Vienna, Austria
    Medical University of Vienna
Mar 20, 2023

Advanced Solid Malignancies Trial in Worldwide (Ami-LC-MD, Ami-LC, Ami-HC)

Recruiting
  • Advanced Solid Malignancies
  • West Hollywood, California
  • +13 more
Jan 31, 2023

ST Elevation Myocardial Infarction Trial in Isehara (Percutaneous coronary intervention)

Enrolling by invitation
  • ST Elevation Myocardial Infarction
  • Percutaneous coronary intervention
  • Isehara, Kanagawa, Japan
    Tokai University Hospital
Nov 21, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Daratumumab, Pomalidomide)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Tucson, Arizona
  • +191 more
Aug 11, 2022

Healthy Volunteers Trial in Anaheim, Overland Park (BIIB107, Placebo)

Recruiting
  • Healthy Volunteers
  • Anaheim, California
  • +2 more
Jan 9, 2023

Healthy Volunteers Trial (ARGX-119, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • ARGX-119
  • Placebo
  • (no location specified)
Jan 2, 2023

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

Active, not recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir - Injectable Suspension (CAB LA)
  • Rilpivirine - Injectable Suspension (RPV LA)
  • Macon, Georgia
  • +29 more
May 31, 2023

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022